Nuna

Company Overview

Snapshot

Founded in June 2023 by Eli Bliah and Lea Bliah, Nuna operates with 1–10 employees. The company is currently in the Pre-Funding stage, focusing on developing its patented edible bioreactor platform.

Business overview

Nuna is pioneering an edible bioreactor platform designed for scalable cell and algae growth. This technology allows for the cultivation of plant or animal cells within protective capsules, enabling efficient and decentralized production of alternative proteins. By integrating the growth environment directly into each capsule, Nuna eliminates the need for expensive stainless-steel bioreactors and complex cold-chain logistics, thereby reducing infrastructure costs and enhancing scalability for industries focused on sustainable proteins, aquaculture, and food security.

Company Intelligence Q&A

What is Nuna's core technology?

Nuna has developed a patented edible bioreactor platform that grows plant or animal cells within protective capsules. This system facilitates efficient, decentralized production of alternative proteins by embedding the growth environment directly into each capsule.

When was Nuna founded?

Nuna was founded in June 2023 by co-founders Eli Bliah and Lea Bliah.

What problem does Nuna's technology address?

Nuna's technology aims to eliminate the need for costly stainless-steel bioreactors and complex cold-chain logistics in cell and algae cultivation. This modular approach allows for the growth of algae and cultivated animal cells during storage or transport, reducing infrastructure costs and improving scalability.

Which markets does Nuna target?

Nuna targets geomarkets including Europe, the United States, Israel, and Asia, focusing on the agriculture and food technologies sector, particularly in sustainable proteins and novel food ingredients.

What is Nuna's current product development stage?

Nuna is currently in the R&D stage for its edible bioreactor system, actively developing its patented technology to enable scalable cell and algae growth within protective capsules. This stage involves refining the bioreactor design and optimizing growth conditions for various cell types.